Kangpu Biopharmaceuticals - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of military and commercial vessels near the Strait of Hormuz, illustrating Iran’s renewed control measures after reversing its brief claim that the waterway was fully open to commercial shipping.

Iran reverses Hormuz opening within 24 hours — IRGC fires on tankers as blockade standoff deepens

Representative image of a legal and workplace rights dispute in India after the National Human Rights Commission notices and the Supreme Court filing intensified focus on the Nashik workplace harassment and coercion case involving Tata Consultancy Services.

TCS Nashik case: NHRC directs three-year POSH audit across all TCS branches

Nexstar Media Group (NASDAQ: NXST) faces post-closing merger shock as judge halts TEGNA integration

Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling

Read More

Pharma Industry News

Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818

Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of…

bypharmanewsdaily

October 14, 2019

web analytics